Amniotic membrane transplantation for persistent corneal ulcers and perforations in acute fungal keratitis

Hung-Chi Chen1, Hsin-Yuan Tan, Ching-Hsi Hsiao

  • 1Department of Ophthalmology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.

Cornea
|June 20, 2006
PubMed
Abstract

Insights

Amniotic membrane transplantation (AMT) effectively promotes healing and prevents perforation in fungal keratitis. Continued antifungal treatment is crucial to manage persistent or recurrent infections after AMT.

Area of Science:

  • Ophthalmology
  • Microbiology

Background:

  • Acute fungal keratitis presents a significant challenge to ocular health, often leading to vision loss.
  • Amniotic membrane transplantation (AMT) is explored as a therapeutic adjunct for severe cases.

Observation:

  • This study evaluated 23 patients with fungal keratitis undergoing AMT.
  • AMT was performed during active infection in 16 patients and inactive infection in 7.
  • Epithelialization rates were high (75% active, 100% inactive), but 25% of active cases required therapeutic penetrating keratoplasty.

Findings:

  • AMT significantly promoted epithelial healing in fungal keratitis, with higher success in inactive phases.
  • Corneal perforation was prevented in some cases, but persistent infection occurred in 8.7% of patients.
  • Over half of the eyes (52.2%) achieved useful vision post-treatment.

Implications:

  • AMT is a valuable tool for managing fungal keratitis, aiding epithelial repair and preventing perforation.
  • Close monitoring and continued antifungal therapy are essential to mitigate risks of persistent or recurrent fungal infections.
  • AMT offers a viable option with no rejection risk, improving visual outcomes in select fungal keratitis patients.

Related Concept Videos